Proteasome inhibition induces nuclear translocation of the dioxin receptor through an Sp1 and protein kinase C-dependent pathway

Journal of Molecular Biology

Volumn 333, Issue 2, 2003, Pages 249-260

  Santiago Josefat, Belen ^a   Fernandez Salguero, Pedro M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Dioxin receptor; Dioxin receptor nuclear translocator; Proteasome; Protein kinase C; Sp1

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; AROMATIC HYDROCARBON RECEPTOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CARRIER PROTEIN; HYPOXIA INDUCIBLE FACTOR 1BETA; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; REGULATOR PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE OVEREXPRESSION; MOUSE; NONHUMAN; NUCLEAR IMPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0141758091     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.08.020     Document Type: Article

References (60)

1. Pohjanvirta R., Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. 46:1994;483-549.
2. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140:1996;173-179.
3. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA. 97:2000;779-782.
4. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 268:1995;722-726.
5. Lahvis G.P., Lindell S.L., Thomas R.S., McCuskey R.S., Murphy C., Glover E., et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl Acad. Sci. USA. 97:2000;10442-10447.
6. Abbott B.D., Schmid J.E., Pitt J.A., Buckalew A.R., Wood C.R., Held G.A., Diliberto J.J. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol. Appl. Pharmacol. 155:1999;62-70.
7. Benedict J.C., Lin T.M., Loeffler I.K., Peterson R.E., Flaws J.A. Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol. Sci. 56:2000;382-388.
8. Alexander D.L., Ganem L.G., Fernandez-Salguero P., Gonzalez F., Jefcoate C.R. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J. Cell Sci. 111:1998;3311-3322.
9. Shimba S., Wada T., Tezuka M. Arylhydrocarbon receptor (AhR) is involved in negative regulation of adipose differentiation in 3T3-L1 cells: AhR inhibits adipose differentiation independently of dioxin. J. Cell Sci. 114:2001;2809-2817.
10. Ma Q., Whitlock J.P. Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell. Biol. 16:1996;2144-2150.
11. Elferink C.J., Ge N.L., Levine A. Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol. Pharmacol. 59:2001;664-673.
12. Zaher H., Fernandez-Salguero P.M., Letterio J., Sheikh M.S., Fornace A.J. Jr, Roberts A.B., Gonzalez F.J. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol. Pharmacol. 54:1998;313-321.
13. Elizondo G., Fernandez-Salguero P., Sheikh M.S., Kim G.Y., Fornace A.J., Lee K.S., Gonzalez F.J. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol. Pharmacol. 57:2000;1056-1063.
14. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340.
15. Whitlock J.P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:1999;103-125.
16. Whitlock J.P. Jr, Okino S.T., Dong L., Ko H.P., Clarke-Katzenberg R., Ma Q., Li H. Cytochromes P450 5: induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. 10:1996;809-818.
17. Gonzalez F.J., Fernandez-Salguero P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab. Dispos. 26:1998;1194-1198.
18. Safe S. Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol. Lett. 120:2001;1-7.
19. Beischlag T.V., Wang S., Rose D.W., Torchia J., Reisz-Porszasz S., Muhammad K., et al. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol. Cell. Biol. 22:2002;4319-4333.
20. Adachi J., Mori Y., Matsui S., Takigami H., Fujino J., Kitagawa H., et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276:2001;31475-31478.
21. Xie W., Evans R.M. Orphan nuclear receptors: the exotics of xenobiotics. J. Biol. Chem. 276:2001;37739-37742.
22. Carrier F., Owens R.A., Nebert D.W., Puga A. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12:1992;1856-1863.
23. Chen Y.-H., Tukey R.H. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271:1996;26261-26266.
24. Long W.P., Pray-Grant M., Tsai J.C., Perdew G.H. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 53:1998;691-700.
25. Reyes H., Reisz-Porszasz S., Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science. 256:1992;1193-1195.
26. Li H., Dong L., Whitlock J.P. Jr. Transcriptional activation function of the mouse Ah receptor nuclear translocator. J. Biol. Chem. 269:1994;28098-28105.
27. Chang C.Y., Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol. Cell. Biol. 18:1998;525-535.
28. Wang F., Gao J.X., Mimura J., Kobayashi A., Sogawa K., Fujii-Kuriyama Y. Structure and expression of the mouse AhR nuclear translocator (mArnt) gene. J. Biol. Chem. 273:1998;24867-24873.
29. Han I., Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17:1997;2550-2558.
30. Su K., Roos M.D., Yang X., Han I., Paterson A.J., Kudlow J.E. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J. Biol. Chem. 274:1999;15194-15202.
31. Armstrong S.A., Barry D.A., Leggett R.W., Mueller C.R. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272:1997;13489-13495.
32. Daniel S., Zhang S., DePaoli-Roach A.A., Kim K.H. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem. 271:1996;14692-14697.
33. Rohlff C., Ahmad S., Borellini F., Lei J., Glazer R.I. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 272:1997;21137-21141.
34. Black A.R., Jensen D., Lin S.Y., Azizkhan J.C. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 274:1999;1207-1215.
35. Fojas de Borja P., Collins N.K., Du P., Azizkhan-Clifford J., Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 20:2001;5737-5747.
36. Alroy I., Soussan L., Seger R., Yarden Y. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol. Cell. Biol. 19:1999;1961-1972.
37. Liu A., Prenger M.S., Norton D.D., Mei L., Kusiak J.W., Bai G. Nerve growth factor uses Ras/ERK and phosphatidylinositol 3-kinase cascades to up-regulate the N-methyl-D-aspartate receptor 1 promoter. J. Biol. Chem. 276:2001;45372-45379.
38. Milanini-Mongiat J., Pouyssegur J., Pages G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J. Biol. Chem. 277:2002;20631-20639.
39. Pal S., Claffey K.P., Cohen H.T., Mukhopadhyay D. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J. Biol. Chem. 273:1998;26277-26280.
40. Rafty L.A., Khachigian L.M. Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. Nucl. Acids Res. 29:2001;1027-1033.
41. Lu Z., Liu D., Hornia A., Devonish W., Pagano M., Foster D.A. Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol. 18:1998;839-845.
42. Kang B.S., French O.G., Sando J.J., Hahn C.S. Activation-dependent degradation of protein kinase C eta. Oncogene. 19:2000;4263-4272.
43. Junoy B., Maccario H., Mas J.L., Enjalbert A., Drouva S.V. Proteasome implication in phorbol ester- and GnRH-induced selective down-regulation of PKC (alpha, epsilon, zeta) in alpha T(3)-1 and L beta T(2) gonadotrope cell lines. Endocrinology. 143:2002;1386-1403.
44. Santiago-Josefat B., Pozo-Guisado E., Mulero-Navarro S., Fernandez-Salguero P.M. Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Mol. Cell. Biol. 21:2001;1700-1709.
45. Hankinson O. Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc. Natl Acad. Sci. USA. 76:1979;373-376.
46. Hankinson O. Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants of mouse hepatoma line, Hepa-1, and assignment of recessive mutants to three complementation groups. Somatic Cell Genet. 9:1983;497-514.
47. Probst M.R., Reisz-Porszasz S., Agbunag R.V., Ong M.S., Hankinson O. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44:1993;511-518.
48. Su K., Yang X., Roos M.D., Paterson A.J., Kudlow J.E. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem. J. 348:2000;281-289.
49. Jackson S.P., Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell. 55:1988;125-133.
50. Kadonaga J.T., Carner K.R., Masiarz F.R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1987;1079-1090.
51. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
52. Song Z., Pollenz R.S. Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation. Mol. Pharmacol. 62:2002;806-816.
53. Deroo B.J., Rentsch C., Sampath S., Young J., DeFranco D.B., Archer T.K. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22:2002;4113-4123.
54. Rolfs A., Kvietikova I., Gassmann M., Wenger R.H. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272:1997;20055-20062.
55. Elbi C., Misteli T., Hager G.L. Recruitment of dioxin receptor to active transcription sites. Mol. Biol. Cell. 13:2002;2001-2015.
56. McGuire J., Okamoto K., Whitelaw M.L., Tanaka H., Poellinger L. Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain. J. Biol. Chem. 276:2001;41841-41849.
57. Kohle C., Hassepass I., Bock-Hennig B.S., Walter Bock K., Poellinger L., McGuire J. Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells. Arch. Biochem. Biophys. 402:2002;172-179.
58. Jackson S.P., MacDonald J.J., Lees-Miller S., Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell. 63:1990;155-165.
59. Long W.P., Perdew G.H. Lack of an absolute requirement for the native aryl hydrocarbon receptor (AhR) and AhR nuclear translocator transactivation domains in protein kinase C-mediated modulation of the AhR pathway. Arch. Biochem. Biophys. 371:1999;246-259.
60. Martin-Romero F.J., Santiago-Josefat B., Correa-Bordes J., Gutierrez-Merino C., Fernandez-Salguero P. Potassium-induced apoptosis in rat cerebellar granule cells involves cell-cycle blockade at the G1/S transition. J. Mol. Neurosci. 15:2000;155-165.